Matches in Wikidata for { <http://www.wikidata.org/entity/Q92419412> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92419412 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92419412 description "scientific article published on 28 July 2019" @default.
- Q92419412 description "wetenschappelijk artikel" @default.
- Q92419412 description "наукова стаття, опублікована 28 липня 2019" @default.
- Q92419412 name "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 name "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 type Item @default.
- Q92419412 label "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 label "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 prefLabel "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 prefLabel "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 P1433 Q92419412-BFB92BDA-37C4-4998-806C-1B79E88E203F @default.
- Q92419412 P1476 Q92419412-D08E0D0D-E173-4211-96BE-3B05B2D19E46 @default.
- Q92419412 P2093 Q92419412-0C813DFB-7D38-4DB1-A1CE-1D3701B3A05F @default.
- Q92419412 P2093 Q92419412-4EC40E85-AF17-4B70-90AB-D75160131F98 @default.
- Q92419412 P2093 Q92419412-54F6A5B4-B0B8-40D5-8E7C-23D844531054 @default.
- Q92419412 P2093 Q92419412-6E6E05CE-F7A1-4FA7-A943-DDCDE5F821A6 @default.
- Q92419412 P2093 Q92419412-8E9FF467-7C35-4C2B-B0C9-760F67A5511A @default.
- Q92419412 P2093 Q92419412-C0329FBE-3BEC-4543-808E-C929956AA535 @default.
- Q92419412 P2093 Q92419412-C9550882-976A-4B6B-AF93-94EE01E65BF6 @default.
- Q92419412 P2093 Q92419412-D2EB83B6-CA53-4D69-B317-64236F821B5C @default.
- Q92419412 P2093 Q92419412-E85F5BC1-47D9-4DA4-A54F-88BFC5BEBAF7 @default.
- Q92419412 P2093 Q92419412-F9F2F0DB-462D-4F44-89F0-04E964230E3E @default.
- Q92419412 P2093 Q92419412-FF308225-D973-4EEA-A748-590AF5ACDEB8 @default.
- Q92419412 P304 Q92419412-754CD84B-886C-4260-860A-AF8FADCD50B4 @default.
- Q92419412 P31 Q92419412-F7EE1742-83BB-4EB3-9A26-EFCD66A5B7A1 @default.
- Q92419412 P356 Q92419412-1906994E-8326-42B8-BE02-469763FEA597 @default.
- Q92419412 P478 Q92419412-4E116261-E632-48C6-BCF7-62F864F86AA8 @default.
- Q92419412 P577 Q92419412-3F957F5B-A58C-4DD5-811E-02FEF21D8C03 @default.
- Q92419412 P698 Q92419412-A59E5DC8-52BB-4CA8-8F07-0BD8EBC72F05 @default.
- Q92419412 P921 Q92419412-A24AE239-94C3-411D-A848-5DBC1E6962D2 @default.
- Q92419412 P356 J.EJMECH.2019.07.044 @default.
- Q92419412 P698 31382120 @default.
- Q92419412 P1433 Q3008624 @default.
- Q92419412 P1476 "Novel dual inhibitors targeting CDK4 and VEGFR2 synergistically suppressed cancer progression and angiogenesis" @default.
- Q92419412 P2093 "Borui Zhao" @default.
- Q92419412 P2093 "Jianyu Zheng" @default.
- Q92419412 P2093 "Rong Xiang" @default.
- Q92419412 P2093 "Shengyong Yang" @default.
- Q92419412 P2093 "Tianqi Wang" @default.
- Q92419412 P2093 "Wei Zhou" @default.
- Q92419412 P2093 "Yan Fan" @default.
- Q92419412 P2093 "Yi Shi" @default.
- Q92419412 P2093 "Yongtao Li" @default.
- Q92419412 P2093 "Zhi Huang" @default.
- Q92419412 P2093 "Zhongxiang Qin" @default.
- Q92419412 P304 "111541" @default.
- Q92419412 P31 Q13442814 @default.
- Q92419412 P356 "10.1016/J.EJMECH.2019.07.044" @default.
- Q92419412 P478 "181" @default.
- Q92419412 P577 "2019-07-28T00:00:00Z" @default.
- Q92419412 P698 "31382120" @default.
- Q92419412 P921 Q539568 @default.